US and EMEA name officers participating in staff exchange programme
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration and the European Medicines Agency have reached a milestone in their international collaboration efforts. At the Drug Information Association’s 45th annual meeting in San Diego, US, on 24 June, the regulatory authorities named two officials that they have chosen to participate in the first-ever permanent staff exchange arrangement between the agencies. Karen Finn reports.
You may also be interested in...
Global medtech alliance approves six new member associations
An emerging alliance of medical technology industry associations representing innovative companies that currently develop and manufacture 85% of the world's medical devices, diagnostics and equipment has approved the membership applications of six more associations, bringing the total number of members to 19.
Global medtech alliance approves six new member associations
An emerging alliance of medical technology industry associations representing innovative companies that currently develop and manufacture 85% of the world's medical devices, diagnostics and equipment has approved the membership applications of six more associations, bringing the total number of members to 19.
US FDA scrutiny of DTC genetic tests continues
The US FDA's devices unit has written to three genetic testing companies warning them that they may be marketing their products and services without clearance by the agency.